Sreeram (Ram) Ramagopalan is the Global Head for Real World Evidence for Market Access at Roche. Dr Ramagopalan’s team strategically plans and executes real world research studies to obtain and maintain access for Roche medicines. Dr Ramagopalan holds a PhD in Epidemiology from the University of Oxford, as well as an MSc in Epidemiology from the London School of Hygiene and Tropical Medicine. Prior to Roche, Dr Ramagopalan led European Real World Evidence teams at Bristol Myers Squibb and the life-sciences consultancy Evidera. He is an international expert in real world evidence with over 270 peer reviewed publications.